Login to Your Account



Newly named Ogeda closes out $20M series B round for drug discovery

By Cormac Sheridan
Staff Writer

Wednesday, October 19, 2016

DUBLIN – Ogeda SA, the company formerly known as Euroscreen SA, celebrated its change of moniker with a €2 million (US$2.2 million) add-on to its series B round, taking the total to €18 million (US$20 million).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription